glp 1 agonist anesthesia New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review AAOMS may update anesthesia guide

In addition, GLP-1RAs are valuable in the treatment and prevention of diseases of the nervous and cardiovascular system, endocrine disorders, or metabolic diseases due to their neuroprotective, cardiovascular protective, and metabolic regulatory effects

Table 2 provides a summary of the AGAs recommendations on the management of patients on GLP-1 RAs prior to endoscopy [37]

Direct Liver Impact: It has a profound effect on reducing liver fat (hepatic steatosis)

PIONEER 6 compared oral semaglutide to placebo in 3183 patients with T2DM and established CV disease or CV risk factors only [21]

The current report discusses the mechanism of action, classification, pharmacokinetic and pharmacodynamic properties of various GLP-1 RAs

Mattison McGee This is genuinely a miracle drug